Literature DB >> 18317635

AIDS in childhood: cardiac involvement with and without triple combination antiretroviral therapy.

Maria do Carmo Soares Alves Cunha1, Aristarco Gonçalves de Siqueira Filho, Silvia Reis dos Santos, Thalita Fernandes de Abreu, Ricardo Hugo S de Oliveira, Denise Marcelino Baptista, Marylane Christian Feitosa Dantas, Márcia Fernanda Carvalho, Luciane Gaspar Guedes.   

Abstract

OBJECTIVE: To describe the prevalence of cardiac abnormalities in the echocardiogram of children with AIDS followed up in a reference service at 18+/-6 months of AIDS confirmed diagnosis.
METHODS: A cross-section study with a cohort after 18+/-6 months of AIDS diagnosis. The study included a total of 93 children with a confirmed diagnosis of AIDS with vertical transmission, with no malignancies and who underwent echocardiogram (echo) during cardiologic evaluation. Cardiac abnormalities were assessed in patients who were not treated (G1) and patients who were treated (G2) with combination antiretroviral therapy.
RESULTS: When diagnosed with AIDS, the children were on average 3.07 years old and 50.50% were female. The combination regimen with antiretroviral agents was used by 47 patients (G2). Cardiac involvement was present in 40 children (43.00%). The presence of left ventricular dysfunction (G1: 39.10%; G2: 10.60%) and the isolated enlargement of left ventricle (G1: 6.60%; G2: 14.90%) were the most frequent findings. We observed a significant association between the groups without and with combination antiretroviral therapy asregards the presence of left ventricular dysfunction (PR= 3.42; [1.41-8.26]; p = 0.02) and malnutrition (PR = 1.79; [1.00-3.20]; p = 0.04).
CONCLUSION: Cardiac involvement was frequent in children with AIDS and left ventricular dysfunction was the most common abnormality on echocardiogram. There was a statistically significant difference between the groups with and without triple combination treatment as regards the presence of left ventricular dysfunction and malnutrition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317635     DOI: 10.1590/s0066-782x2008000100003

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  6 in total

1.  Abnormal cardiac strain in children and young adults with HIV acquired in early life.

Authors:  Amy Sims; Lowell Frank; Russell Cross; Sarah Clauss; David Dimock; Julia Purdy; Irene Mikhail; Rohan Hazra; Colleen Hadigan; Craig Sable
Journal:  J Am Soc Echocardiogr       Date:  2012-04-26       Impact factor: 5.251

2.  Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.

Authors:  Vitor Guerra; Erin C Leister; Paige L Williams; Thomas J Starc; Steven E Lipshultz; James D Wilkinson; Russell B Van Dyke; Rohan Hazra; Steven D Colan
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-09       Impact factor: 2.205

3.  Cardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy.

Authors:  Judith Namuyonga; Sulaiman Lubega; Victor Musiime; Peter Lwabi; Irene Lubega
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

Review 4.  Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature.

Authors:  Arnaud Grégoire L'Huillier; Klara Maria Posfay-Barbe; Hiba Pictet; Maurice Beghetti
Journal:  Front Pediatr       Date:  2015-04-07       Impact factor: 3.418

5.  Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children.

Authors:  Nikmah S Idris; Michael M H Cheung; Diederick E Grobbee; David Burgner; Nia Kurniati; Cuno S P M Uiterwaal
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

Review 6.  Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents.

Authors:  Robert E Shaddy; Aneesh Thomas George; Thomas Jaecklin; Eimear Nic Lochlainn; Lalit Thakur; Rumjhum Agrawal; Susan Solar-Yohay; Fabian Chen; Joseph W Rossano; Thomas Severin; Michael Burch
Journal:  Pediatr Cardiol       Date:  2017-12-20       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.